Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 7/20 | 0.47 |
| ▸ | CA7 | P43166 | 7/20 | 0.47 |
| ▸ | CA9 | Q16790 | 7/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 7/20 | 0.47 |
| ▸ | AKR1B10 | O60218 | 6/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 6/20 | 0.47 |
| ▸ | CA4 | P22748 | 4/20 | 0.47 |
| ▸ | CA6 | P23280 | 4/20 | 0.47 |
| ▸ | CA5A | P35218 | 4/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.47 |
| ▸ | CA1 | P00915 | 6/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | TYR | P14679 | 3/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.44 |
| ▸ | MET | P08581 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.43 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 2/20 | 0.42 |
| ▸ | F3 | P13726 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22694187 | 0.86 | AKR1B10 (0.48) | CA12CA7CA9CA14AKR1B10 | |
| SCHEMBL22694189 | 0.84 | CYP3A4 (0.45) | AKR1B10AKR1B1METPTGS2CYP2D6 | |
| SCHEMBL22694185 | 0.84 | SNCA (0.41) | AKR1B10AKR1B1MAOBPTGS2BACE1 | |
| SCHEMBL22694182 | 0.82 | CYP3A4 (0.47) | PTGS2CYP2D6CYP2C9 | |
| SCHEMBL22694184 | 0.82 | AKR1B10 (0.30) | AKR1B10AKR1B1 | |
| SCHEMBL22694186 | 0.81 | EPHX2 (0.57) | CA12CA7CA9CA14AKR1B1 | |
| SCHEMBL22694220 | 0.80 | ALOX5 (0.52) | METPTGS2CYP2D6CYP2C9PKM | |
| SCHEMBL22694219 | 0.80 | GABBR2 (0.48) | MAOBPTGS2CYP2C9 | |
| SCHEMBL22694188 | 0.80 | NFKB1 (0.44) | CA4CA1CA2MAOB | |
| SCHEMBL22694292 | 0.76 | LMNA (0.41) | CA12CA7CA9CA14CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200369605-A1 | ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369605-A1 | ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | PAG1, SLC6A5, LBR | CA12 2743/4885CA7 345/4885CA9 856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.